Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$115M |
| 2 |
Apple
AAPL
|
+$95.4M |
| 3 |
DXC Technology
DXC
|
+$91M |
| 4 |
Pfizer
PFE
|
+$66.9M |
| 5 |
Johnson & Johnson
JNJ
|
+$60.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$121M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$51.9M |
| 3 |
HP
HPQ
|
+$50.3M |
| 4 |
HOLX
Hologic
HOLX
|
+$45M |
| 5 |
Carlisle Companies
CSL
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Financials | 14.59% |
| 3 | Healthcare | 13.17% |
| 4 | Industrials | 11.08% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Ecopetrol
EC
$35.6B
| $2.14M | ﹤0.01% |
235,147
+39,680
| +20% | +$371K |
|
2202
Flotek Industries
FTK
$1.35B
| $2.11M | ﹤0.01% |
39,300
+323
| +0.8% | +$20.3K |
|
2203
Matrix Service
MTRX
$329M
| $2.11M | ﹤0.01% |
225,550
-222,138
| -50% | -$2.5M |
|
|
LDR
2204
DELISTED
Landauer Inc
LDR
| $2.11M | ﹤0.01% |
40,293
+247
| +0.6% | +$12.7K |
|
|
ACHN
2205
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.1M | ﹤0.01% |
457,341
+2,850
| +0.6% | +$11.5K |
|
|
EXAC
2206
DELISTED
Exactech Inc
EXAC
| $2.09M | ﹤0.01% |
70,248
+16,330
| +30% | +$479K |
|
|
OKSB
2207
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $2.09M | ﹤0.01% |
81,706
+456
| +0.6% | +$11.5K |
|
2208
Match Group
MTCH
$8.45B
| $2.08M | ﹤0.01% |
119,865
+16,401
| +16% | +$301K |
|
|
PGNX
2209
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.08M | ﹤0.01% |
306,843
-35,361
| -10% | -$261K |
|
|
PSTB
2210
DELISTED
Park Sterling Corp.
PSTB
| $2.08M | ﹤0.01% |
175,085
+1,007
| +0.6% | +$12K |
|
2211
Expro Ltd
XPRO
$1.95B
| $2.08M | ﹤0.01% |
41,718
+14,374
| +53% | +$745K |
|
|
AT
2212
DELISTED
Atlantic Power Corporation
AT
| $2.07M | ﹤0.01% |
862,341
+43,982
| +5% | +$109K |
|
|
UCTT
2213
Ultra Clean Holdings
UCTT
$3.82B
| $2.05M | ﹤0.01% |
109,440
+53,940
| +97% | +$1.09M |
|
|
XOG
2214
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $2.05M | ﹤0.01% |
152,375
+13,712
| +10% | +$214K |
|
|
FLXN
2215
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.05M | ﹤0.01% |
101,214
+513
| +0.5% | +$10.7K |
|
|
RSO
2216
DELISTED
Resource Capital Corp.
RSO
| $2.03M | ﹤0.01% |
199,840
+42,858
| +27% | +$412K |
|
2217
SolarEdge
SEDG
$1.97B
| $2.03M | ﹤0.01% |
101,566
+19,694
| +24% | +$349K |
|
|
LORL
2218
DELISTED
Loral Space and Communications, Inc.
LORL
| $2.03M | ﹤0.01% |
48,809
-53,756
| -52% | -$2.12M |
|
2219
e.l.f. Beauty
ELF
$5.65B
| $2.02M | ﹤0.01% |
74,113
+44,557
| +151% | +$1.19M |
|
2220
Nutanix
NTNX
$17.5B
| $2.01M | ﹤0.01% |
99,539
+58,856
| +145% | +$1.03M |
|
2221
ANI Pharmaceuticals
ANIP
$1.71B
| $1.99M | ﹤0.01% |
42,428
+3,522
| +9% | +$170K |
|
2222
Stratasys
SSYS
$763M
| $1.98M | ﹤0.01% |
84,706
+7,500
| +10% | +$193K |
|
2223
Sunrun
RUN
$2.4B
| $1.96M | ﹤0.01% |
275,620
+47,082
| +21% | +$254K |
|
2224
Accuray
ARAY
$36.8M
| $1.96M | ﹤0.01% |
413,032
+4,812
| +1% | +$21.1K |
|
|
INWK
2225
DELISTED
InnerWorkings, Inc.
INWK
| $1.96M | ﹤0.01% |
168,482
+19,231
| +13% | +$207K |
|
Similar funds
Charles Schwab's Q2 2017 Portfolio in Review
As of Q2 2017, Charles Schwab held 3,236 positions worth $106B, up 6.5% from $99.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.41B of net new capital in Q2 2017, opening 179 new positions and adding to 2,227 existing holdings. Its largest new stake was DXC Technology: 1,371,360 shares worth $91M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was HP, an estimated $50.3M trimmed.
- Charles Schwab's largest Q2 2017 buy was DXC Technology: 1,371,360 shares worth $91M.
- Charles Schwab added most to ExxonMobil in Q2 2017, an estimated $115M increase.
- Charles Schwab's biggest Q2 2017 reduction was HP, cutting an estimated $50.3M.
- Charles Schwab fully exited Yahoo Inc in Q2 2017, selling an estimated $121M.
- Charles Schwab's ten largest holdings make up 14% of its $106B portfolio in Q2 2017.
- Charles Schwab opened 179 new positions and closed 133 in Q2 2017.
- Charles Schwab's portfolio value rose 6.5% quarter-over-quarter to $106B.
Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.